Select Page

November 15, 2004 – PsychoGenics, Inc., a leader in preclinical neurobiology and CNS drug discovery solutions, today announced an expansion of its executive management team. Effective immediately Paul McGonigle, Ph.D., co-founder and former CEO of NeuroGenix Corporation, has been named Chief Scientific Officer, and Jeff Schneider, Ph.D., Associate Research Professor at Carnegie Mellon University’s Robotics Institute, has been appointed Chief Informatics Officer.